Storys zum Thema Health

16.03.2017 – 07:01
Shire Pharmaceuticals Group Plc
Shire Receives European Approval for Label Extension of CINRYZE®(C1 inhibitor [human]) to Prevent and Treat Hereditary Angioedema (HAE) Attacks in Paediatric Patients with HAE
Zug, Switzerland (ots/PRNewswire) - CINRYZE is now the first and only Hereditary angioedema treatment approved for routine prevention in paediatrics Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the European Commission (EC) has approved a label extension granting three new indications for CINRYZE® (C1 inhibitor ...
mehr
14.03.2017 – 18:29
European Hematology Association (EHA)
EuroBloodNet Aims for Better Care for Patients with Rare Blood Disorders
Vilnius, Lithuania (ots/PRNewswire) - Patients suffering from rare blood disorders will benefit from networks of excellence across the European Member States. At the third conference on European Reference Networks (ERNs) yesterday in Vilnius, Lithuania, EuroBloodNet was officially awarded as one of the recently approved ERNs. ERNs is an initiative of the European ...
mehr
14.03.2017 – 15:23
Groupe ROQUETTE
Roquette Commits to BioPharma Market
Lestrem, France (ots/PRNewswire) - Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries Roquette, a global leader in innovative plant-based pharmaceutical ingredients, announces its commitment to provide new product offerings to address the growing demand for excipients and raw materials for the biopharmaceutical market. (Logo: ...
mehr
10.03.2017 – 11:14
Merck Healthcare Germany
New Merck Technology Aims to Further Optimize Embryo Incubation and Assessment
Darmstadt, Germany (ots/PRNewswire) - - Merck integrates innovative Eeva® Test with Geri(TM) incubation platform, bringing individualized incubation and outcome prediction together - Geri(TM) humidity technology aims to further advance incubation to precisely monitor and manage the humidity level in the incubator Merck, a leading science and technology company, today ...
mehr
08.03.2017 – 08:01
Royal DSM
DSM and Evonik Establish Joint Venture for Omega-3 Fatty Acids From Natural Marine Algae for Animal Nutrition
Kaiseraugst, Switzerland (ots/PRNewswire) - - Breakthrough for animal nutrition to reduce impact on ocean resources and making it more sustainable - Commercial-scale facility for algal oil for salmon aquaculture and pet food to be built in the United States - Further develop and produce a high value algal oil with a ...
mehr
07.03.2017 – 09:00
Debiopharm International SA
Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics
Lausanne (ots) - Change in name reflects new strategy to invest in smart data, therapeutics and diagnostics Debiopharm Diagnostics SA, the strategic investment fund of Debiopharm Group(TM) (www.debiopharm.com), announced its new strategy and the change of name to Debiopharm Innovation Fund SA effective today. With the aim of speeding up innovations that radically ...
mehr

07.03.2017 – 07:01
GfK SE
European Optics Market Records Over EUR17 Billion in 2016
Milan (ots/PRNewswire) - GfK's sales tracking of four key European retail optics markets (Italy, France, Spain and Germany), shows a turnover of EUR17.6 billion for total year 2016. This is a sales value growth of 0.9 percent compared to the previous year. GfK released the findings at the international MIDO 2017 trade fair in Milan. GfK tracks sales data in the optician channel for sunglasses, frames, spectacle lenses, ...
mehr
03.03.2017 – 16:01
LEO Pharma
LEO Pharma Announces Positive Results From Phase 2b Clinical Study for Tralokinumab in Atopic Dermatitis
Ballerup, Denmark and Orlando, Florida (ots/PRNewswire) - LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD), a serious and chronic form of eczema. Tralokinumab is an investigational ...
mehr
02.03.2017 – 13:31
Accuray Europe
Accuray Launches New Cancer Patient Websites
Sunnyvale, California (ots/PRNewswire) - The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis, according to the American Cancer Society. Accuray Incorporated (NASDAQ: ARAY) is launching http://www.cyberknife.com and http://www.tomotherapy.com to provide an additional resource for cancer patients to turn to for information about their disease and potential ...
mehr
02.03.2017 – 09:02
Royal Philips
Philips Unveils Access CT at 2017 European Congress of Radiology to Expand CT Capabilities for Cost-conscious Healthcare Organizations
Amsterdam and Vienna (ots/PRNewswire) - - iDose[4] proprietary reconstruction technique lowers operating costs by increasing tube life - iFlow intelligent workflow platform enables consistent image quality from operator-to-operator to reduce rescans Royal Philips (http://www.philips.com/) (NYSE: PHG; AEX: PHIA) ...
mehr
02.03.2017 – 08:30
Merck Healthcare Germany
NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild-type mCRC
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - More patients now able to receive a standard-of-care treatment with Erbitux plus FOLFIRI or FOLFOX - NICE's recommendation is a significant step forward in Merck's aspiration to ensure cancer patients have optimal access to effective ...
mehr
01.03.2017 – 08:55
Royal Philips
Philips Introduces Advanced Radiology Solutions at 2017 European Congress of Radiology to Address Evolving Healthcare Demands and Support the Changing Role of the Radiologist
Amsterdam and Vienna (ots/PRNewswire) - Royal Philips (http://www.usa.philips.com/) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled new advanced radiology solutions at the 2017 European Congress of Radiology (https://www.myesr.org/ecr-2017) (ECR), beginning March 1 at the Austria Center ...
mehr

28.02.2017 – 13:02
Merck and Pfizer
FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US and UK-based media - Second Biologics License Application accepted by the FDA for avelumab - Prognosis for urothelial carcinoma is currently poor, particularly when the disease has metastasized Merck and Pfizer Inc. today announced that the US ...
mehr
27.02.2017 – 14:49
ALK
ALK's ACARIZAX® Data Results in Significant Change to the GINA Asthma Management Strategy: Sublingual Allergy Immunotherapy (SLIT) Recommended as a Treatment Option in Patients With House Dust Mite Allergic Asthma
Hørsholm, Denmark (ots/PRNewswire) - ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that for the first time, allergy immunotherapy is now recommended as a treatment option in the Global Initiative for Asthma (GINA) report: Global Strategy for Asthma Management and Prevention. This global strategy is a ...
mehr
24.02.2017 – 14:06
Merck Healthcare Germany
Merck Receives Positive CHMP Opinion for New Pergoveris® Fertility Pen
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. and UK based media - Ready-to-use pre-filled pen provides a convenient treatment option for patients - Simplified injection device for self-administration comes in multiple doses, addressing individual needs of patients Merck, a leading science and technology company, today announced that the European ...
mehr
24.02.2017 – 13:19
Shire Pharmaceuticals Group Plc
CHMP Recommends EU Conditional Marketing Authorisation for Natpar® (Parathyroid Hormone) for Patients with Chronic Hypoparathyroidism
Zug, Switzerland (ots/PRNewswire) - This Press Release is intended for Global Use If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment[1] Shire plc (LSE: SHP, ...
mehr
23.02.2017 – 14:02
Tillotts Pharma AG
Tillotts Pharma in Germany Dedicated to Gastrointestinal Health
Berlin (ots/PRNewswire) - Tillotts Pharma is strengthening its presence in the German market: the Berlin office was opened in January 2017 under the management of Magdalena Kritikos. The portfolio includes Entocort® for the treatment of Crohn's disease, Asacol® for the treatment of ulcerative colitis, and VistaPrep® for bowel preparation before endoscopy. With ...
mehr
22.02.2017 – 17:17
Royal Philips
Philips Reinforces Leadership in Image-guided Therapy Solutions with Global Launch of Next Generation Azurion Platform
Amsterdam (ots/PRNewswire) - - Developed in collaboration with leading hospitals worldwide, Philips Azurion (https://www.usa.philips.com/healthcare/resources/landing/azurion) is an innovative image-guided therapy platform that allows clinicians to easily and confidently perform a wide range of routine and complex ...
mehr

14.02.2017 – 00:59
Janssen Sciences Ireland UC
Janssen Announces Two-drug Combination of Dolutegravir and Rilpivirine Demonstrates Efficacy in Maintaining Viral Suppression in Phase III Clinical Studies
Seattle (ots/PRNewswire) - - First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC (Janssen) announced positive results ...
mehr
09.02.2017 – 11:03
Merck Healthcare Germany
Cladribine Tablets Significantly Reduced Brain Atrophy in Patients With Multiple Sclerosis
Darmstadt, Germany (ots/PRNewswire) - - Post hoc analysis of Phase III CLARITY study data recently published in Multiple Sclerosis Journal showed statistically significant reduction in brain atrophy in patients on a short course of investigational Cladribine Tablets over two years compared with patients receiving placebo - These findings correlated with effects on ...
mehr
01.02.2017 – 19:38
Shire Pharmaceuticals Group Plc
New Data From Shire Aim To Help Close the Diagnosis and Treatment Gap for People With Hemophilia
Zug, Switzerland (ots/PRNewswire) - Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare diseases, presented its new estimate of the Global Annual Bleed Rate (GABR), an effort to build on current global ...
mehr
01.02.2017 – 08:02
Novo Nordisk
Flexible Storage Options can Impact Daily Use of FVIII Treatments in People with Haemophilia A
Paris (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Poster #P024 Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) demonstrated the ...
mehr
31.01.2017 – 14:03
Kantar TNS and Nestlé Waters
Kantar TNS Survey for Nestle Waters on Water Consumption
Paris (ots/PRNewswire) - Water needs is a common ground across populations and cultures according to the survey but local habits and knowledge still affect water consumption Kantar TNS and Nestle Waters published a survey on attitudes about water consumption in seven countries: China, France, Italy, Mexico, the UK, the US and Turkey. To view the Multimedia News Release, please click: ...
mehr
27.01.2017 – 14:48
Jacoti bvba
Jacoti Named as Global Mobile Awards 2017 Nominee for the Best Use of Mobile for Accessibility & Inclusion Category
Wevelgem, Belgium (ots/PRNewswire) - Jacoti Hearing Suite, an innovative set of hearing applications created by Jacoti bvba, has been named a Global Mobile Awards 2017 Nominee. Products entered in this prestigious program are judged by a preeminent panel of more than 250 independent judges from across the world, ...
mehr

27.01.2017 – 08:41
Allergan plc
Allergan Launches Juvéderm® VOLITE - An Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months
Dublin (ots/PRNewswire) - -- Allergan enters skin quality category with new injectable product using VYCROSS® technology[1] for use on the face, neck, décolletage and hands[2] -- Hyaluronic Acid (HA) gel designed to improve skin's smoothness (absence of fine lines), hydration and elasticity for up to nine months ...
mehr
23.01.2017 – 13:01
Resverlogix Corp.
Resverlogix Provides Groundbreaking Results in Patients with Severe Kidney Impairments
Calgary, Alberta (ots/PRNewswire) - Several Key Proteins That Drive Kidney (Renal) Disease and Dialysis Risk are Downregulated After a Single Dose of Apabetalone Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announced preliminary results from the New Zealand based Phase 1 trial with severe kidney (renal) impaired patients. The data showed ...
mehr
20.01.2017 – 11:43
Merck Healthcare Germany
Merck and Genea Open Centre of Excellence for Fertility
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. based media - Merck is broadening its efforts to support ART clinics to achieve excellence for patients - Through leading edge education and training, the Centre of Excellence aims to support clinics to achieve consistent and high level of outcome Merck, a leading science and technology company, today announced the opening of its first Centre of Excellence (CoE) ...
mehr
17.01.2017 – 17:32
International Union Against Cancer (UICC)
Sectors Converge to Change the Future of Cancer in Urban Populations
Davos, Switzerland (ots/PRNewswire) - - New city-level initiative launched in partnership between the Union for International Cancer Control (UICC), the World Economic Forum and World Bank - A commitment to saving lives by helping country and city leaders improve the health of their citizens and reduce inequities in access to quality cancer treatment and care - A ...
mehr
06.01.2017 – 07:01
DS Biopharma
DS Biopharma (DS) Announces that Recruitment has Begun in Two Separate Phase 2b Atopic Dermatitis Studies with Lead Compound DS107 as well as the Successful Completion of a Phase 1 trial for Follow on Compound DS109
Dublin (ots/PRNewswire) - DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has begun in two separate Phase 2b atopic dermatitis (AD) studies with its lead compound DS107. An Oral DS107 Phase 2b study (called 'ADvance') in 300 ...
mehr
20.12.2016 – 13:02
InSightec
The Japanese Ministry of Health, Labor and Welfare Approved Exablate Neuro System for the Treatment of Essential Tremor
Tokyo and Haifa, Israel (ots/PRNewswire) - INSIGHTEC (http://www.insightec.com/JP/), the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its Exablate Neuro system for the non-invasive treatment of essential tremor in ...
mehr

Vorherige30313233343536373839Nächste